I love the new adjective “shkrelic”, implying a particularly obnoxious and sociopathic expression of greed.
The sense I get is that they don’t want to be held hostage to the pharmatrolls when trying to get re-imbursed by the insurers for claims. Even if they’re still charging a premium for a generic they manufacture it’ll be far less that what a shkrelic company would charge, so the negotiation between hospital and insurer will be a little easier. It’s a small step, but anything that eliminates (or at least reduces the income of) one of the parasitic middlemen who thrive off the broken American system is a good step.
